Good for retail to have insights afforded to brokers/instos who no doubt speak to management before writing these updates. John knows his stuff.
Hopefully, retail can now also put the volume profile together to understand big boys are buying, so as not sell out cheap. Many have waited 5 years for these outcomes sitting on losses. Whilst I added in substantially recently in the mid 30's for some trading parcels, I have ditched that idea for now. These volumes will protect the SP from dropping too much between now and the scheduled approval date. IMO
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-416
-
- There are more pages in this discussion • 681 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4001 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 52 | 1 |
View Market Depth
| Last trade - 10.02am 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable